SCHEMBL1090266

SCHEMBL1090266

O=C(C(c1ccccc1)c1ccccc1)N1CCC(N2CCCCC(Nc3nccc(N4CCCCCC4)n3)C2)CC1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CXCR4 P61073 1/20 0.51
▸ KDM4E B2RXH2 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ ADRB2 P07550 1/20 0.45
▸ HRH4 Q9H3N8 3/20 0.45
▸ ACACB O00763 1/20 0.41
▸ CHRM1 P11229 2/20 0.41
▸ MAPK8 P45983 4/20 0.41
▸ IDH1 O75874 3/20 0.40
▸ CCNK O75909 2/20 0.40
▸ CDK12 Q9NYV4 2/20 0.40
▸ CYP3A4 P08684 2/20 0.40
▸ NPY2R P49146 1/20 0.39
▸ MAPK9 P45984 2/20 0.39
▸ CCNE1 P24864 1/20 0.39
▸ CDK2 P24941 1/20 0.39
▸ MAPK10 P53779 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1090462 0.98 CXCR4 (0.51) CXCR4KDM4EALDH1A1ADRB2HRH4
SCHEMBL1090810 0.96 CXCR4 (0.54) CXCR4KDM4EALDH1A1ADRB2HRH4
SCHEMBL1089667 0.92 CXCR4 (0.49) CXCR4KDM4EALDH1A1ADRB2HRH4
SCHEMBL1090935 0.91 CXCR4 (0.50) CXCR4KDM4EALDH1A1ADRB2HRH4
SCHEMBL1091227 0.88 HRH4 (0.50) CXCR4KDM4EALDH1A1HRH4ACACB
SCHEMBL1090233 0.87 CXCR4 (0.52) CXCR4KDM4EALDH1A1ADRB2HRH4
SCHEMBL1091241 0.87 CXCR4 (0.53) CXCR4KDM4EALDH1A1HRH4ACACB
SCHEMBL1089763 0.86 CXCR4 (0.47) CXCR4KDM4EALDH1A1HRH4ACACB
SCHEMBL1089827 0.86 HRH4 (0.47) CXCR4HRH4ACACBMAPK8CCNK
SCHEMBL1091248 0.85 HRH4 (0.48) CXCR4HRH4ACACBMAPK8CCNK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-06-21 — — US disclosed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 — — US disclosed
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-02 — — US disclosed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 — — US disclosed
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-19 — — US disclosed
EP-1571146-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-09-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 CXCR4 1/4885KDM4E 2001/4885ALDH1A1 916/4885
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof CXCR4, CXCL12, CXCR3 CXCR4 1/4885KDM4E 2001/4885ALDH1A1 916/4885
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 CXCR4 1/4885KDM4E 2001/4885ALDH1A1 916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback